Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07081217 · ClinicalTrials.gov registry record · Early Phase 1
Radiocaine Safety Study In Healthy Human Subjects
A Early Phase 1 study of Healthy Subjects, sponsored by Lutroo Imaging.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT07081217 is a Early Phase 1 study of Healthy Subjects that is actively recruiting participants, run by Lutroo Imaging. The registered enrollment target is 6 participants, below the 129-participant average among 69 other Healthy Subjects trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07081217, a Early Phase 1 study of Healthy Subjects, is actively recruiting participants, sponsored by Lutroo Imaging.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a Phase 1, single-center, open-label study evaluating the safety, biodistribution, and radiation dosimetry of Radiocaine™, an investigational fluorine-18-labeled PET radiotracer designed to bind voltage-gated sodium channels in pain-related peripheral nerves. The study will enroll healthy adult volunteers and aims to inform future clinical development in pain imaging. Radiocaine™ is being developed as a potential imaging biomarker for the localization and quantification of pain.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Intravenous Radiocaine
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2025-06-17 |
| Est. Completion | 2026-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07081217
The ClinicalTrials.gov registry entry for NCT07081217 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 129-participant average among 69 other Healthy Subjects trials with a reported enrollment target (95% lower). The listed sponsor is Lutroo Imaging, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Subjects appearing as the primary indexed condition, and to 1 intervention - of which Intravenous Radiocaine is the first listed.
NCT07081217 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07081217 about?
NCT07081217 is a clinical study titled "Radiocaine Safety Study In Healthy Human Subjects". This is a Phase 1, single-center, open-label study evaluating the safety, biodistribution, and radiation dosimetry of Radiocaine™, an investigational fluorine-18-labeled PET radiotracer designed to bind voltage-gated sodium channels in pain-related peripheral nerves. The study will enroll healthy ad...
What is the current status of trial NCT07081217?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2025-06-17. Estimated completion is 2026-04.
What conditions does trial NCT07081217 study?
This clinical trial studies the following conditions: Healthy Subjects.
What interventions are being tested in trial NCT07081217?
The interventions under investigation include: Intravenous Radiocaine (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07081217?
This trial is sponsored by Lutroo Imaging, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07081217 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Subjects
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Single-tracer Multiparametric PET Imaging
RECRUITING · Early Phase 1
-
Methemoglobin Concentration in High Dose Inhaled Nitric Oxide
ACTIVE NOT RECRUITING · Early Phase 1
-
Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
RECRUITING
-
Phase I Study of ICP-332 in Healthy Subjects
RECRUITING · Phase 1
-
Optimizing Ultrasound-induced Anti-inflammation in Human Subjects
RECRUITING · NA
-
A Recovery and Lifespan Study Using INTERCEPT Red Blood Cells Prepared Using the INTERCEPT Blood System for RBCs With AS-1
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.